Elmukhtar Habas

Elmukhtar Habas

Profile ID RP-002-7250 Joined 2024-05-29 3 articles
0Connections
4
Total Views
3
Total Publications
67
Publication Views

Articles(3)

Authors: Elmukhtar M. Habas, Khaled Alarbi, Ala Habas, Mohamed Baghi, Eshrak Habas, Amnna Rayani, Abdusslam Said, Kalifa Farfar, AlMehdi Errayes, Gamal Alfitori, Aml Habas, Abdel Naser Elzouki

DOI: 10.18231/j.yjom.2024.004

Volume3
Issue2
Pages81-96
Abstract

Hypertension (HTN) may not be properly controlled despite the ideal blood pressure (BP)-lowering drugs and good patient compliance. These scenarios emphasize the need for innovative approaches to treat HTN cases that are difficult to manage pharmaceutically. Numerous recent studies have documented the effectiveness of renal denervation (RDN) therapy in reducing sympathetic nerve system (SNS) overactivity. Although this therapy is invasive and expensive, its appropriate use in specific cases is still being refined. SNS overactivity is documented in HTN, chronic kidney disease (CKD), and end-stage renal disease patients. Over the past decade, RDN therapy has been used in different countries to treat HTN, with a positive response in most cases. However, some hospitals have no resources or interventionists to perform these procedures. Nonetheless, there is an increased number of physicians expressing interest in using RDN in sustained HTN therapy and prevention of CKD progression. There are no consensus guidelines worldwide; however, some societies have developed guidelines for using RDN based on updated information covering the BP-lowering mechanism, efficacy, patient selection, post- and preprocedural assessment, and procedural safety. In this review, we aimed to evaluate the effectiveness of the RDN procedure for treating HTN and prevention of CKD development and progression.

Authors: Elmukhtar M. Habas*, Ala Habas, Abdusslam Said, Amnna Rayani, Kalifa Farfar, Eshrak Habas, Gamal Alfitori, Almehdi Errayes, Aml Habas, Abdel Naser Elzouki

DOI: 10.18231/j.yjom.2024.006

Volume3
Issue2
Pages102-113
Abstract

Pleural effusion (PE) is a common feature of various diseases. The most common causes of PEs are infection, pulmonary embolism, and heart failure. Other diseases include rheumatological diseases, ovarian hyperstimulation syndrome, liver cirrhosis, hypoalbuminemia, and nephrotic syndrome. The principle of PE pathogenesis is either increased fluid production or decreased fluid removal from the pleural cavity, mainly by the parietal pleural layer. According to the underlying cause, the pathogenesis could be due to increased permeability, decreased oncotic pressure or increased hydrostatic pressure of parietal pleural capillaries, increased fluid oncotic pressure, tumor invasion to the pleura, increased lymphatic vessel hydrostatic pressure, lung inflammation, and increased lung interstitial fluid content. Exploring the underlying cause and pathogenic mechanism is the best approach and is immensely helpful in planning the treatment of PE. Treating the underlying cause is the primary approach in treating PEs; thoracocentesis, pleurodesis, pleurectomy, and other possible modalities are applied when indicated, mainly to relieve symptoms. Hence, this review article will discuss the conceivable pathophysiological mechanisms of PEs, common etiologies, radiological diagnostic modalities, and the available therapeutic options.

Authors: Elmukhtar Habas, Mehdi Errayes, Eshrak Habas, Khalifa L Farfar, Gamal Alfitori, Ala E Habas, Amnna Rayani, Abdel-Naser Y Elzouki

DOI: 10.7759/cureus.25269

Volume14
Issue5
Pagese25269
Abstract

Chronic kidney disease (CKD) is a common disease in the Islamic regions. Dehydration occurs after prolonged fasting, particularly in hot and humid climates. In the Arabic months' calendar, Ramadan is a month of maximum given deeds, where Muslims are required to fast from dawn till sunset. Depending on where you live and when the Ramadan month falls, fasting might last anywhere from 10 to 20 hours or more. In certain circumstances, such as poorly controlled diabetes and advanced CKD patients who are allowed to break their fast, the Ramadan fasting amendment is viable. Some Muslims, however, continue fasting despite these circumstances, placing themselves at risk, which is not allowed in the Islamic religion. There are no medical recommendations that specify who should and should not fast. Nonetheless, the recommendations have been extracted from several published studies. The authors searched EMBASE, PubMed, Google Scholar, and Google for publications, research, and reviews. All authors debate and analyze the related articles. Each author was assigned a part or two of the topics to read, study, and summarize before creating the final draft of their given section. Then this comprehensive review was completed after discussion sessions. In conclusion, by the Islamic religion view, fasting Ramadan is mandatory for every wise adult person. People who have chronic diseases or that may deteriorate by fasting are exempted from fasting. It seems that fasting and the associated disease hours are determinant factors to fasting or not fasting. Up to our knowledge, there are no established guidelines for CKD patients and physicians to follow; however, the International Diabetes Federation and Diabetes and Ramadan (IDF-DAR) Practical Guidelines 2021 have been issued for CKD diabetic patients and fasting.

No matching articles

Try another word from the title, author or DOI.

Brief Bio

No bio added yet.

Affiliations

Nothing added yet.

Education

Nothing added yet.

Honors & Awards

Nothing added yet.

Society Memberships

Nothing added yet.

Expertise

Nothing added yet.

Specialty

Nothing added yet.

Other Online Pages

Scholars in the same field

VK
VARUN KUMAR
0 publications
BG
Bhupendra Gupta
0 publications
RS
Ritvik Sharma
0 publications
SJ
shweta jha
ip innovative
0 publications
AD
Abhijit Das
0 publications
ST
Sahista Tarunum
0 publications
ZB
Zenish Bhatti
0 publications
TJ
Tintu Jose
0 publications
LT
LIKHITHA T G
0 publications
SS
Satyaprakash Suman
0 publications
П
Павло
https://orcid.org/0000-0002-7760-9610
0 publications

Following

Nobody here yet.

Followers

Nobody here yet.

3 Publications

0 Contributions

Nothing added yet.

Filter